Black Friday Deal: $15 OFF Forever on All Plans — Limited Time Only!
ATRI logo
NASDAQ · ATRIMedical - Instruments & SuppliesUpdated Not supplied

Atrion Corporation P/E ratio

Current valuation, historical context, and peer comparisons.

Current P/E ratio

64.50×

195388.2% abovethe 10-year annual average

Share price459.92
÷
Earnings per share7.13

Price and EPS in quote currency. Calculation details

Investors are paying 64.50 for every 1 of reported earnings per share.

P/E over time

2014 – 2023
Annual P/ESelected-period average 0.03×
3-year average0.03×3 positive annual observations
5-year average0.04×5 positive annual observations
10-year average0.03×10 positive annual observations
Peer median · TTM214.69×2 peers with positive P/E

Historical P/E ratios

Annual period-end data · 25 observations

ATRI annual P/E history, newest first
Period endP/EChange
Dec 31, 20230.03×+20.4%
Dec 31, 20220.03×-26.2%
Dec 31, 20210.04×+5.4%
Dec 31, 20200.04×-3.2%
Dec 31, 20190.04×-5.4%
Dec 31, 20180.04×+26.0%
Dec 31, 20170.03×-5.2%
Dec 31, 20160.03×+37.9%
View all 25 annual observations +
ATRI annual P/E history, newest first
Period endP/EChange
Dec 31, 20150.02×+1.6%
Dec 31, 20140.02×+6.9%
Dec 31, 20130.02×+34.0%
Dec 31, 20120.02×-10.2%
Dec 31, 20110.02×+7.7%
Dec 31, 20100.02×-5.5%
Dec 31, 20090.02×+50.6%
Dec 31, 20080.01×-27.9%
Dec 31, 20070.02×-87.4%
Dec 31, 20060.13×-4.0%
Dec 31, 20050.14×+14.0%
Dec 31, 20040.12×-18.1%
Dec 31, 20020.15×+88.0%
Dec 31, 20010.08×-99.3%
Dec 31, 200010.85×-10.2%
Dec 31, 199912.08×+1.2%
Dec 31, 199811.94×N/M

Change is relative to the preceding observation. N/M values are excluded from averages.

How ATRI compares

Company P/E vs. peer trailing-12-month ratios

P/E comparison with ATRI and provider-selected peers
CompanyP/E ratio
ATRI logo
ATRI This stockAtrion Corporation
64.50×
CSII logo
CSIICardiovascular Systems, Inc.
N/M
CMRX logo
CMRXChimerix, Inc.
N/M
CDMO logo
CDMOAvid Bioservices, Inc.
N/M
ICPT logo
ICPTIntercept Pharmaceuticals, Inc.
5.57×
ASLN logo
ASLNASLAN Pharmaceuticals Limited
N/M
PETQ logo
PETQPetIQ, Inc.
423.80×
ICVX logo
ICVXIcosavax, Inc.
N/M
HARP logo
HARPHarpoon Therapeutics, Inc.
N/M

Peers are selected by the data provider. Business models and earnings definitions can differ.

Put the numbers in context

What does ATRI’s P/E tell you?

01

Start with its own history

At 64.50×, ATRI is 195388.2% above its 10-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.

02

Compare like with like

The median of the 2 positive peer ratios above is 214.69×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.

03

Check what drives earnings

One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.

Keep your research connected

Take ATRI into your spreadsheet

Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.

Explore Wisesheets
Quarterly P/E · latest quarter
=WISE("ATRI", "PE Ratio", "LQ")
LQ selects the latest reported quarter. Requires the Wisesheets add-in. See available data

Sources & calculation methodology

Current P/E

Share price 459.92 ÷ EPS 7.13 = 64.50×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Not supplied; this is not a real-time trading quote.

History & averages

Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.

Data definitions and limitations

The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.

ATRI P/E ratio: common questions

The essentials behind the numbers.

Atrion Corporation's current P/E is 64.50× based on the quote data last updated Not supplied. It represents the share price divided by reported earnings per share. Prices and earnings may refresh on different schedules.
Annual P/E uses earnings for a completed fiscal year. Trailing-12-month (TTM) P/E uses the latest four quarters, while forward P/E uses forecast earnings. These are not interchangeable. This page labels peer ratios as TTM and shows dated annual or quarterly historical observations; it does not show forward estimates.
N/M means not meaningful: the feed has no positive P/E for that observation. Negative or zero earnings should not be ranked as a low positive valuation multiple. N/M observations are excluded from the averages shown above.
Divide the share price by earnings per share (EPS). For example, a share price of 100 and EPS of 5 gives a P/E of 20×. This page uses the price and EPS supplied together in the quote when both are positive.
Price timestamps, EPS definitions, share classes, adjustments, and fiscal periods can differ. A forward P/E also uses forecast earnings rather than reported earnings. Compare the inputs and as-of dates before comparing two displayed ratios.
Not necessarily. The average describes previous market pricing, not fair value. Changes in earnings quality, growth expectations, debt, accounting, and business risk can justify a different multiple today.